Transcutaneous Blood Gas Monitoring in Respiratory Care

Transcutaneous blood gas monitoring is a noninvasive technique used to estimate arterial oxygen and carbon dioxide levels through the skin. It provides continuous insight into a patient’s respiratory status, making it especially useful in settings where frequent arterial blood gas sampling is impractical or risky.

Commonly used in neonatal and critical care, this method allows clinicians to monitor trends in oxygenation and ventilation in real time. Understanding how it works, along with its advantages and limitations, is essential for accurate interpretation and effective patient management.

What Is Transcutaneous Monitoring?

Transcutaneous blood gas monitoring is designed to provide continuous estimates of arterial oxygenation and ventilation by measuring gases that diffuse through the skin. The two primary values obtained are:

• Transcutaneous oxygen tension (PtcO₂)
• Transcutaneous carbon dioxide tension (PtcCO₂)

These values are measured using a sensor that is applied directly to the skin surface. Unlike arterial blood gas analysis, which provides intermittent data points, transcutaneous monitoring offers continuous trending information. This allows clinicians to observe changes in a patient’s respiratory status in real time and respond more quickly to deterioration or improvement.

Although transcutaneous monitoring does not directly measure arterial blood, it can approximate arterial values under the right conditions. Because of this, it is most often used as a supplement to arterial blood gas analysis rather than a replacement.

Principles of Operation

The effectiveness of transcutaneous monitoring depends on creating conditions that allow gases to diffuse from the capillaries through the skin to the sensor. This is achieved by heating the skin beneath the electrode, typically to a temperature between 42°C and 44°C.

Heating serves several important purposes:

• It causes capillary vasodilation, which increases local blood flow
• It enhances the diffusion of gases across the skin
• It reduces the difference between capillary and arterial gas tensions

This process is often referred to as arterialization of the capillary blood. By increasing perfusion and permeability, the sensor is able to detect gas tensions that more closely resemble arterial values.

Once the gases diffuse through the skin, the sensor measures their partial pressures and displays them as PtcO₂ and PtcCO₂. These measurements are continuous, making the system particularly useful for monitoring trends over time.

Measurement Characteristics

Transcutaneous Carbon Dioxide (PtcCO₂)

PtcCO₂ is generally considered the more reliable parameter in transcutaneous monitoring. Carbon dioxide diffuses more readily through tissues than oxygen, which allows for more accurate and responsive measurements.

PtcCO₂ typically correlates well with arterial PaCO₂, especially when skin perfusion is adequate. In many cases, it can track changes within approximately ±5 mm Hg of arterial values. Because of this, it is widely used to monitor ventilation.

Clinically, PtcCO₂ is useful for:

• Assessing ventilation status
• Detecting trends in hypercapnia or hypocapnia
• Evaluating the effectiveness of ventilatory support
• Monitoring patients on mechanical ventilation

Note: Heating the sensor increases local CO₂ production, which can cause PtcCO₂ readings to be slightly higher than PaCO₂. A correction factor is often applied to estimate arterial values more accurately.

Transcutaneous Oxygen (PtcO₂)

PtcO₂ provides an estimate of arterial oxygen tension, but it is less reliable than PtcCO₂. Oxygen diffuses less efficiently through tissues, and its measurement is more dependent on local perfusion and skin conditions.

Under optimal circumstances, PtcO₂ can correlate with arterial PaO₂. However, in many clinical situations, it is used primarily to monitor trends rather than absolute values.

Factors that can affect PtcO₂ accuracy include:

• Reduced skin perfusion
• Edema
• Thick skin
• Vasoconstriction

Note: Because of these limitations, pulse oximetry has largely replaced PtcO₂ for routine monitoring of oxygenation. However, transcutaneous oxygen monitoring may still be useful in certain populations, particularly neonates.

Purpose and Clinical Significance

The primary goal of transcutaneous monitoring is to provide continuous insight into a patient’s respiratory status. This allows clinicians to detect changes more quickly than with intermittent arterial blood gas sampling.

It is particularly valuable in situations where frequent blood draws are impractical or risky. For example, in neonatal patients, repeated arterial sampling can lead to significant blood loss and complications.

Key benefits include:

• Continuous monitoring of trends
• Early detection of respiratory deterioration
• Reduced need for invasive procedures
• Improved patient comfort

Note: Because it provides ongoing data, transcutaneous monitoring is especially useful for evaluating how patients respond to changes in therapy, such as adjustments in ventilator settings or oxygen delivery.

Clinical Applications

Neonatal and Pediatric Care

Transcutaneous monitoring is most commonly used in neonates and infants. Their thinner skin and better perfusion allow for more accurate measurements. It is frequently used in neonatal intensive care units to monitor oxygenation and ventilation while minimizing blood loss.

Adult Critical Care

In adult patients, transcutaneous monitoring can be used to assess ventilation status, particularly in those receiving mechanical ventilation or experiencing respiratory failure. It provides an additional tool for tracking changes in PaCO₂ over time.

Procedural Monitoring

During procedures involving sedation or anesthesia, ventilation may be compromised. Transcutaneous monitoring allows clinicians to continuously assess respiratory status and detect hypoventilation early.

Sleep Studies

In sleep medicine, transcutaneous CO₂ monitoring is often used to detect hypoventilation and assess nocturnal ventilation patterns.

Emergency and Transport Settings

Transcutaneous monitoring can be useful during patient transport or in emergency situations where arterial blood gas analysis is not readily available. It provides continuous data that can guide clinical decisions.

Chronic Respiratory Disease Management

Patients with chronic respiratory conditions such as COPD may benefit from transcutaneous CO₂ monitoring to assess trends in CO₂ retention and evaluate treatment effectiveness.

Advantages of Transcutaneous Monitoring

Transcutaneous blood gas monitoring offers several advantages over traditional arterial blood gas analysis:

• It is noninvasive and reduces the need for arterial punctures
• It provides continuous, real-time data
• It improves patient comfort
• It reduces complications such as infection and bleeding
• It allows for better trend analysis over time

Note: These advantages make it a valuable tool in many clinical settings, particularly when continuous monitoring is needed.

Limitations and Sources of Error

Despite its benefits, transcutaneous monitoring has several limitations that must be considered.

Dependence on Skin Perfusion

Adequate skin perfusion is essential for accurate measurements. Conditions such as shock, hypotension, hypothermia, and vasoconstriction can reduce blood flow to the skin and lead to inaccurate readings.

Skin Characteristics

Variations in skin thickness, edema, and age can affect gas diffusion. For example, adult skin is thicker than neonatal skin, which can reduce accuracy.

Sensor Issues

Improper calibration, poor sensor contact, or damaged membranes can lead to inaccurate measurements. Regular calibration and proper placement are essential.

Lag Time

There is often a delay between changes in arterial gas levels and transcutaneous readings. This is particularly true for oxygen measurements. As a result, transcutaneous monitoring is better suited for trend analysis rather than rapid decision-making.

Risk of Skin Injury

Because the sensor is heated, there is a risk of skin irritation or burns. To prevent this, the sensor must be repositioned regularly and the skin should be monitored closely.

Interpretation of Results

Interpreting transcutaneous values requires an understanding of their relationship to arterial blood gases.

• PtcCO₂ generally correlates well with PaCO₂ and is reliable for monitoring ventilation trends
• PtcO₂ is less reliable and is influenced by perfusion and local conditions

Clinicians should avoid relying solely on absolute values and instead focus on trends over time. An initial arterial blood gas measurement is often used to establish a baseline for comparison.

Note: A key clinical principle is to monitor trends rather than depend entirely on individual readings.

Calibration and Correlation with Arterial Blood Gases

Accurate use of transcutaneous monitoring requires initial calibration and correlation with arterial blood gas (ABG) values. Because transcutaneous measurements are indirect, clinicians must establish a baseline relationship between transcutaneous and arterial values early in the monitoring process.

When monitoring begins, an ABG sample should be obtained to determine the patient’s true PaO₂ and PaCO₂. These values are then compared with PtcO₂ and PtcCO₂ readings to establish a gradient. This baseline allows clinicians to interpret subsequent transcutaneous values more effectively.

For oxygen, PtcO₂ is generally expected to fall within approximately ±15% of PaO₂ under stable conditions. However, this relationship can vary depending on perfusion and skin characteristics.

For carbon dioxide, PtcCO₂ values are typically higher than PaCO₂ due to local CO₂ production caused by heating. A correction factor is often used:

PaCO₂ ≈ PtcCO₂ ÷ 1.6

This relationship helps estimate arterial CO₂ levels more accurately, although individual variation may still occur.

Note: Regular recalibration is necessary to maintain accuracy, particularly if the patient’s condition changes or if there are concerns about sensor performance.

Site Selection and Sensor Placement

Proper site selection is essential for obtaining accurate measurements and preventing complications. The chosen site should have good perfusion, relatively thin skin, and minimal pressure.

Recommended Sites

For neonates:

• Upper chest
• Right upper chest for preductal measurements
• Abdomen
• Inner thigh

For children and adults:

• Upper chest
• Inner upper arm

Note: These locations are preferred because they provide consistent blood flow and allow for better gas diffusion.

Sites to Avoid

Certain areas should be avoided due to poor accuracy or increased risk of injury:

• Bony prominences
• Areas with thick adipose tissue
• Pressure points
• Edematous tissue
• Regions with thick skin
• Hands and feet

Note: Using inappropriate sites can lead to unreliable readings and increase the likelihood of skin complications.

Sensor Application

The sensor must be applied securely to ensure good contact with the skin. Any gaps, air bubbles, or poor adhesion can interfere with gas diffusion and lead to inaccurate measurements.

Before application:

• The skin should be clean and dry
• Hair may need to be removed in adult patients
• The sensor membrane should be intact

Note: Once applied, the sensor heats the skin to promote arterialization and begins measuring gas tensions continuously.

Safety Considerations and Complications

Although transcutaneous monitoring is noninvasive, it is not without risk. The primary concern is thermal injury to the skin caused by the heated sensor.

Mechanism of Injury

The sensor must be heated to enhance gas diffusion. Prolonged exposure to elevated temperatures can lead to:

• Skin irritation
• Redness
• Blistering
• Burns

Note: These complications are more likely in patients with fragile or sensitive skin, such as neonates.

Prevention Strategies

To minimize the risk of injury:

• Rotate the sensor site regularly, typically every 2 to 4 hours
• Inspect the skin frequently for signs of irritation
• Use appropriate temperature settings based on patient age and condition
• Avoid placing the sensor on compromised skin

Actions if Complications Occur

If signs of skin injury are observed:

• Move the sensor to a new site immediately
• Allow the affected area to recover
• Discontinue monitoring if injury occurs at multiple sites

Note: Prompt recognition and intervention are essential to prevent more serious complications.

Factors Affecting Accuracy

Several physiologic and technical factors can influence the accuracy of transcutaneous monitoring.

Perfusion Status

Adequate perfusion is critical. Conditions that reduce blood flow to the skin can significantly impair accuracy, including:

• Shock
• Hypotension
• Hypothermia
• Peripheral vasoconstriction

Note: In these situations, transcutaneous values may underestimate true arterial gas tensions.

Skin Integrity and Thickness

Skin characteristics vary among patients and can affect gas diffusion. Thicker skin, edema, or scarring can reduce the accuracy of measurements. Neonates generally have thinner skin, which allows for better diffusion and more reliable readings compared to adults.

Temperature and Environmental Factors

External temperature and patient body temperature can influence readings. Hypothermia, for example, can reduce perfusion and affect the accuracy of both PtcO₂ and PtcCO₂.

Sensor Performance

Technical issues with the sensor can also affect accuracy. These include:

• Improper calibration
• Damaged membranes
• Poor contact with the skin
• Equipment malfunction

Note: Routine checks and maintenance are necessary to ensure reliable performance.

Comparison with Other Monitoring Methods

Arterial Blood Gas Analysis

Arterial blood gas analysis remains the standard for measuring oxygenation and ventilation. It provides precise values for PaO₂, PaCO₂, and pH. However, ABG sampling is invasive and provides only intermittent data. Transcutaneous monitoring complements ABG analysis by offering continuous trend information.

Pulse Oximetry

Pulse oximetry measures oxygen saturation (SpO₂) noninvasively and is widely used for monitoring oxygenation.

Compared to PtcO₂:

• Pulse oximetry is easier to use
• It provides rapid, continuous readings
• It is less affected by local skin conditions

Note: As a result, pulse oximetry has largely replaced transcutaneous oxygen monitoring in many clinical settings.

Capnography

Capnography measures end-tidal carbon dioxide (EtCO₂) and is commonly used to assess ventilation.

Compared to PtcCO₂:

• Capnography reflects exhaled CO₂ rather than arterial CO₂
• It may be less accurate in patients with ventilation-perfusion mismatch

Note: Transcutaneous CO₂ monitoring provides a closer estimate of arterial CO₂ and can be useful when capnography is unreliable.

Role in Mechanical Ventilation

Transcutaneous monitoring is particularly useful in patients receiving mechanical ventilation. It allows clinicians to continuously assess ventilation and detect changes in PaCO₂ without frequent ABG sampling.

Key applications include:

• Monitoring response to ventilator adjustments
• Detecting hypoventilation or hyperventilation
• Assessing weaning readiness
• Identifying equipment malfunction

Note: Because PtcCO₂ closely reflects PaCO₂, it is especially valuable for managing ventilated patients and optimizing ventilator settings.

Role in Neonatal Care

In neonatal intensive care units, transcutaneous monitoring is widely used due to its noninvasive nature and ability to provide continuous data.

Benefits in neonates include:

• Reduced need for blood sampling
• Lower risk of anemia
• Improved comfort
• Continuous monitoring of oxygenation and ventilation

Note: It is particularly useful for premature infants, who are at higher risk for complications related to both hypoxia and hypercapnia.

Best Practices for Clinical Use

To maximize the effectiveness of transcutaneous monitoring, clinicians should follow several best practices:

• Always correlate initial readings with ABG values
• Focus on trends rather than absolute numbers
• Ensure proper sensor placement and calibration
• Monitor skin condition regularly
• Reposition the sensor as recommended
• Be aware of factors that may affect accuracy

Note: Following these guidelines helps ensure safe and effective use of the technology.

Transcutaneous Blood Gas Monitoring Practice Questions

1. What is transcutaneous blood gas monitoring?
Transcutaneous blood gas monitoring is a noninvasive method used to estimate arterial oxygen and carbon dioxide levels through the skin.

2. What are the two main values measured during transcutaneous monitoring?
The two main values are PtcO₂ and PtcCO₂.

3. What does PtcO₂ represent?
PtcO₂ represents transcutaneous oxygen tension.

4. What does PtcCO₂ represent?
PtcCO₂ represents transcutaneous carbon dioxide tension.

5. Why is transcutaneous monitoring considered noninvasive?
It does not require repeated arterial punctures or direct blood sampling.

6. What is the main purpose of transcutaneous blood gas monitoring?
Its main purpose is to provide continuous trending information about oxygenation and ventilation.

7. In which patient population is transcutaneous monitoring most commonly used?
It is most commonly used in neonates and pediatric patients.

8. Why is transcutaneous monitoring especially useful in neonates?
It helps reduce the need for frequent blood sampling and minimizes blood loss.

9. What type of sensor is used for transcutaneous monitoring?
A heated skin electrode or sensor is used.

10. Why is the skin heated during transcutaneous monitoring?
The skin is heated to increase local blood flow and enhance gas diffusion.

11. What temperature range is commonly used to heat the skin?
The sensor is typically heated to about 42°C to 44°C, or sometimes up to 45°C.

12. What does heating the skin do to capillary blood flow?
It causes capillary vasodilation and increases local blood flow.

13. What is meant by arterialization of capillary blood?
It means the capillary blood is made to resemble arterial blood more closely through increased local perfusion.

14. Why does heating improve gas diffusion through the skin?
Heating increases skin permeability and allows oxygen and carbon dioxide to diffuse more easily.

15. Which transcutaneous value is generally more reliable, PtcO₂ or PtcCO₂?
PtcCO₂ is generally more reliable.

16. Why is PtcCO₂ usually more reliable than PtcO₂?
Carbon dioxide diffuses through tissues more readily than oxygen.

17. What arterial value does PtcCO₂ estimate?
PtcCO₂ estimates PaCO₂.

18. What arterial value does PtcO₂ estimate?
PtcO₂ estimates PaO₂.

19. What does PtcCO₂ primarily reflect?
PtcCO₂ primarily reflects ventilation status.

20. What does PtcO₂ primarily reflect?
PtcO₂ primarily reflects oxygenation status.

21. Why is PtcO₂ less reliable than PtcCO₂?
Oxygen diffusion is more limited and is highly dependent on skin perfusion and local conditions.

22. What is one major advantage of transcutaneous monitoring compared with ABG sampling?
It provides continuous data instead of intermittent snapshots.

23. Why should transcutaneous values be correlated with ABG results?
Because transcutaneous measurements are indirect and need baseline comparison with arterial values.

24. What is a key principle when interpreting transcutaneous monitoring?
Trend the numbers rather than relying only on absolute values.

25. Is transcutaneous monitoring a complete replacement for ABG analysis?
No. It should be used as a supplement to ABG analysis when precise values are needed.

26. What is the typical accuracy range of PtcCO₂ compared to PaCO₂?
PtcCO₂ can generally track PaCO₂ within approximately ±5 mm Hg.

27. Why are PtcCO₂ values often higher than PaCO₂?
Heating increases local CO₂ production, causing elevated readings.

28. What correction factor is commonly used for PtcCO₂?
PaCO₂ ≈ PtcCO₂ ÷ 1.6.

29. What is the primary clinical use of PtcCO₂ monitoring?
To assess and trend ventilation status.

30. What type of monitoring is transcutaneous monitoring best suited for?
Trend monitoring over time rather than rapid decision-making.

31. What condition can reduce the accuracy of transcutaneous monitoring due to poor perfusion?
Shock

32. How does hypotension affect transcutaneous readings?
It can decrease skin perfusion and lead to underestimation of values.

33. Why does hypothermia impact transcutaneous monitoring accuracy?
It reduces blood flow to the skin and limits gas diffusion.

34. How does peripheral vasoconstriction affect readings?
It decreases perfusion, reducing measurement accuracy.

35. What effect does edema have on transcutaneous measurements?
It impairs gas diffusion and reduces accuracy.

36. Why is skin thickness important in transcutaneous monitoring?
Thicker skin limits gas diffusion and decreases accuracy.

37. Which patient group has better accuracy with transcutaneous monitoring due to thinner skin?
Neonates

38. What is the primary limitation of PtcO₂ measurements?
They are highly dependent on adequate perfusion and skin conditions.

39. What is the role of pulse oximetry compared to PtcO₂?
Pulse oximetry has largely replaced PtcO₂ for routine oxygen monitoring.

40. What does pulse oximetry measure?
It measures oxygen saturation (SpO₂).

41. How does capnography differ from PtcCO₂ monitoring?
Capnography measures exhaled CO₂, while PtcCO₂ estimates arterial CO₂.

42. Why might capnography be less accurate in certain patients?
Ventilation-perfusion mismatch can affect end-tidal CO₂ readings.

43. What is one advantage of PtcCO₂ over capnography?
It provides a closer estimate of arterial CO₂ levels.

44. Why is continuous monitoring beneficial in respiratory care?
It allows early detection of changes in patient status.

45. What type of monitoring does ABG analysis provide?
Intermittent measurements

46. Why is ABG sampling considered invasive?
It requires arterial puncture.

47. What is one risk associated with repeated ABG sampling?
Infection or bleeding

48. What is a major benefit of transcutaneous monitoring in critical care?
Reduced need for repeated arterial punctures.

49. In which setting is transcutaneous monitoring useful during patient movement?
Transport settings

50. Why is transcutaneous monitoring helpful during sedation or anesthesia?
It can detect hypoventilation early.

51. What is the primary goal of transcutaneous monitoring in clinical practice?
To continuously track changes in oxygenation and ventilation.

52. Why is transcutaneous monitoring useful during mechanical ventilation?
It allows continuous assessment of ventilation without frequent ABGs.

53. What type of changes can transcutaneous monitoring detect early?
Changes in respiratory status such as hypoventilation or hyperventilation.

54. What happens to transcutaneous readings if sensor contact with the skin is poor?
Readings may become inaccurate or unreliable.

55. Why is proper calibration of the sensor important?
It ensures that measurements accurately reflect gas tensions.

56. How often should the sensor site typically be rotated?
Every 2 to 4 hours.

57. What is the main reason for rotating the sensor site?
To prevent skin injury or burns.

58. What type of injury can occur from prolonged sensor heating?
Thermal injury such as burns or blistering.

59. What should be done if skin irritation develops at the sensor site?
Move the sensor to a different site.

60. What action should be taken if blistering occurs at multiple sites?
Discontinue transcutaneous monitoring.

61. Why should the skin be clean and dry before sensor placement?
To ensure proper adhesion and accurate readings.

62. Why might hair need to be removed before sensor placement in adults?
To improve sensor contact with the skin.

63. What could happen if there are air bubbles between the sensor and skin?
Gas diffusion may be impaired, leading to inaccurate readings.

64. What type of monitoring is transcutaneous monitoring classified as?
Continuous, noninvasive monitoring.

65. Why is transcutaneous monitoring valuable in sleep studies?
It helps detect hypoventilation during sleep.

66. What is one use of transcutaneous monitoring during respiratory therapy?
Evaluating response to treatment changes.

67. How can transcutaneous monitoring help detect equipment malfunction?
By showing unexpected changes in gas levels.

68. What happens to PtcO₂ readings in low perfusion states?
They may underestimate true arterial oxygen levels.

69. What happens to PtcCO₂ readings in low perfusion states?
They may become less accurate or unreliable.

70. What is the advantage of trending data over single measurements?
It provides a clearer picture of patient status over time.

71. What type of data does transcutaneous monitoring provide compared to ABGs?
Continuous data instead of intermittent data.

72. Why is transcutaneous monitoring helpful for detecting accidental disconnection?
It shows rapid changes in ventilation status.

73. What is one limitation related to time response in transcutaneous monitoring?
There is a lag between arterial changes and sensor readings.

74. Which gas typically shows a longer lag time in transcutaneous monitoring?
Oxygen

75. Why is lag time important in clinical interpretation?
It limits the use of transcutaneous monitoring for rapid decision-making.

76. What must be established when transcutaneous monitoring is first initiated?
A baseline correlation between transcutaneous values and ABG results.

77. Why is an initial ABG sample important when starting transcutaneous monitoring?
It provides accurate arterial values for comparison and calibration.

78. What is meant by the PaO₂–PtcO₂ gradient?
The difference between arterial oxygen tension and transcutaneous oxygen tension.

79. Under stable conditions, how close should PtcO₂ be to PaO₂?
Within approximately ±15 percent.

80. What does a widening gap between PtcO₂ and PaO₂ suggest?
Possible issues with perfusion or sensor accuracy.

81. What type of monitoring is PtcO₂ best used for?
Trend monitoring rather than precise measurement.

82. What physiologic factor most strongly affects PtcO₂ accuracy?
Skin perfusion

83. What type of tissue should be avoided when selecting a sensor site?
Edematous tissue

84. Why should bony prominences be avoided for sensor placement?
They have poor perfusion and increase the risk of injury.

85. Why are pressure points not ideal for sensor placement?
They can impair blood flow and affect accuracy.

86. Why are hands and feet generally avoided as sensor sites?
They often have poorer perfusion and thicker skin.

87. What is a preductal measurement site in neonates?
The right upper chest.

88. Why is preductal monitoring important in neonates?
It reflects oxygenation before blood mixes through the ductus arteriosus.

89. What is the main advantage of using the upper chest as a sensor site?
It provides good perfusion and consistent readings.

90. What should be checked before applying the sensor membrane?
That it is intact and free of damage.

91. What happens if the sensor membrane is damaged?
Gas measurements may become inaccurate.

92. What is one reason transcutaneous monitoring is useful during patient transport?
It provides continuous data when ABGs are not available.

93. What type of patients benefit from reduced blood sampling?
Neonates and critically ill patients.

94. What does continuous monitoring allow clinicians to evaluate?
The effectiveness of therapeutic interventions.

95. How does transcutaneous monitoring improve patient comfort?
It avoids repeated needle sticks.

96. What complication risk is reduced by avoiding arterial punctures?
Bleeding

97. What infection risk is minimized with noninvasive monitoring?
Risk of bloodstream or local infection.

98. What clinical condition can transcutaneous monitoring help assess in COPD patients?
CO₂ retention

99. Why is transcutaneous monitoring helpful in chronic respiratory disease?
It allows ongoing assessment of ventilation trends.

100. What is the overall role of transcutaneous blood gas monitoring in respiratory care?
To provide continuous, noninvasive assessment of oxygenation and ventilation trends.

Final Thoughts

Transcutaneous blood gas monitoring provides a valuable noninvasive method for continuously assessing oxygenation and ventilation. By measuring PtcO₂ and PtcCO₂ through heated skin electrodes, clinicians can track changes in respiratory status without repeated arterial sampling.

While PtcCO₂ offers reliable insight into ventilation, PtcO₂ is more limited and influenced by perfusion and local conditions. Understanding these differences is essential for accurate interpretation.

When used appropriately and combined with other monitoring tools, transcutaneous monitoring enhances patient care by improving safety, comfort, and the ability to detect trends in respiratory function.